
Language
Search
Product News
- Bruker Introduces HyperQuant™, a Unique Bench-Top NMR Reader to Quantify Hyperpolarization
- Bruker BioSpin's MRI CryoProbe(TM) Selected for 2008 R&D 100 Award for Enabling Preclinical MRI on...
- Bruker BioSpin 1.7mm MicroCryoProbe(TM) Wins R&D 100 Award for Delivering a Tenfold Jump in NMR...
- NMR Newsletter 07/2008
- ParaVision 5.0 released- Routine Workflow for Preclinical MRI
Upcoming Events
Pharmaceutical Reseach
Toxicology screening using NMR
The later that a molecule or molecular class is lost from the drug development pipeline, the higher the financial cost. Minimizing attrition is therefore one of the most important aims of a pharmaceutical discovery programme. Novel technologies that increase the probability of making the right choice early save resources, and promote safety, efficacy and profitability. Metabolomics is a systems approach for studying in vivo metabolic profiles, which promises to provide information on drug toxicity, disease processes and gene function at several stages in the discovery and-development process.

